Quanterix Q4 2024 revenue $35.2M (+11% YoY); FY 2025 guidance $140-146M

Quanterix Corp

Q4 revenue $35.2M, up 11% YoY; net loss $11.6M vs $8.8M prior year.
Full-year 2024 revenue $137.4M (+12%); net loss $38.5M improved $10.2M.
Ended 2024 with $291.7M cash; 2025 cash usage guided at $55-65M (incl. $20M EMISSION payment).
FY 2025 revenue outlook $140-146M (2-6% growth) excluding Lucent Diagnostics and Akoya impact.
Simoa ONE instrument launch planned by end-2025; FDA breakthrough designation for LucentAD Complete.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.